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Introduction 
Incorrect fluid therapy in the perioperative period is associated with a considerable morbidity 
and mortality.[1] Multiple factors have to be considered when devising a rational approach to fluid 
management for patients in the perioperative period. All available information related to patient’s 
pre-existing diseases, preoperative fluid status, surgical interventions and intraoperative anesthetic 
management have to be known. To complete the picture, in-depth clinical examination, 
hemodynamic monitoring and laboratory tests have to be performed (Table 1). Different fluid 
compartments cannot be measured easily in the clinical setting, except for the intravascular fluid 
space. Therefore, patient’s volume status (normo-, hypo- and hypervolemia) is most frequently 
assessed according to cardiac filling, heart function and end-organ perfusion. Because every single 
parameter per se is non-specific, these parameters may best complement each other and the clinical 
evaluation. For adequate assessment of a patient’s fluid balance, all available data have to be taken 
into account like the pieces of a puzzle. Furthermore, to optimize the fluid status and to avoid fluid 
overload, frequent re-evaluations are required, especially during a “fluid trial”, the intravenous 
administration of a specified amount of fluid over a short period of time. 
 
Physical examination and routine monitoring  
There is a sequence of compensatory mechanisms of the body after intravascular fluid loss (i.e. 
hypovolemia due to dehydration or bleeding) to maintain adequate tissue perfusion and end-organ 
oxygenation. In the acute phase, this is mediated predominantly by an increased sympathetic 
outflow. At fluid losses >15% of the blood volume, filling of the jugular veins, preload and stroke 
volume decrease. To maintain optimal cardiac output, the heart rate raises >100 beats/min. 
Simultaneously, afterload is being increased by peripheral vasoconstriction. Therefore, blood 
pressure is sustained during ongoing volume losses and decreases only with a loss >30-40% blood 
volume. The mucous membranes become increasingly dry and turgor of the skin decreases. As 
signs of a reduced tissue perfusion and end-organ oxygenation, a decreased urinary output (<0.5 
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ml/kg/h) and an impaired mental status (confusion, somnolence or coma in severe fluid losses) are 
observed. Unfortunately, some of these typical pathophysiological signs of hypovolemia are not 
reliable indicators of a reduced intravascular fluid status in the perioperative period. Anesthetic 
drugs and stress reactions (due to pain, postoperative nausea and vomiting, body temperature 
derangements or respiratory insufficiency) alter pulse rate, blood pressure and cerebral function. 
Nevertheless, thirst of an awake patient, dry or parched mucus membranes, collapsed jugular veins 
and reduced urinary output are still important sign of hypovolemia in the perioperative clinical 
setting.  
In contrast to the evaluation of the fluid balance in adults, the assessment in children requires 
additional understanding of the age specific physiology: Cardiac output is primarily regulated via 
heart rate and not stroke volume due to the relative myocardial stiffness. Furthermore, elasticity of 
the child’s vessels is higher when compared to that of an adult. Under normal circumstances, the 
heart rate of children is higher and the blood pressure is lower than that of adults limiting the 
validity of these parameters to assess hypovolemia in pediatric patient. Evaluation of the capillary 
refill (i.e., the microcirculation of the skin) is an important test to assess the volume status in 
children. For its assessment, the skin is examined after pressure relief performed by the index 
finger. Delayed normalization of the skin color (>3 seconds after pressure release) indicates a 
prolongation of capillary refill and therefore reduced skin / end-organ perfusion. The formation of a 
skin fold at the child’s back of the hand between the examinator’s thumb and index finger and its 
persistence after pressure relief indicates a decreased skin turgor and is another sign of hypovolemia 
in the child. However, this may be rarely seen in the perioperative period. 
Perioperative hypervolemia may become manifest as arterial hypertension, increased urinary 
output and pulmonary edema (especially in patients with cardiovascular compromise). Signs of 
pulmonary edema include crackles, wheezing and frothy sputum. The diagnosis is confirmed by 
chest X-ray showing edema of the alveoli, increased vascular filling and upper lobe diversion. 
Decreased pulmonary gas exchange may lead to hypoxemia with cyanosis. Ankle edemas and 
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anasarca (edema at the back of a bedridden patient) are chronic signs of hypervolemia and prompt 
the re-evaluation of the patient’s history in the perioperative period. 
 
Advanced hemodynamic monitoring 
Different devices are available for advanced hemodynamic monitoring. They can be clinically 
used in a stepwise escalating approach – from invasive blood pressure measurement, central venous 
cannulation, pulmonary artery catheterization, less invasive, advanced hemodynamic monitoring to 
transesophageal echocardiography (Table 2). Indications are primarily based on the patient’s 
physical status, related cardiovascular and pulmonary co-morbidities and the scheduled 
intervention. For example, invasive blood and central venous pressure monitoring are typically 
applied to a patient with the ASA classification I – III undergoing a surgical intervention with 
anticipated large fluid shifts and losses. Additional sophisticated monitoring including assessment 
of cardiac output is highly desirable for the same interventions in a patient with considerably 
limited cardiac function. The standard technique to measure cardiac output is the pulmonary artery 
catheter since 30 years. Its routine use however, is being questioned and a matter of debate based on 
studies demonstrating conflicting results for its impact on patient’s outcome.[2,3] Today, several 
less invasive advanced hemodynamic monitoring techniques are commercially available. They can 
replace the pulmonary artery catheter under different clinical circumstances and some of these 
techniques additionally allow a more refined fluid assessment.[4] In this section, traditional and 
newly available techniques of hemodynamic monitoring with the aim of evaluating a patient’s fluid 
status are discussed.  
Invasive blood pressure monitoring. Invasive blood pressure measurement is of high value in 
the evaluation of a patient with ongoing intravascular volume losses and / or limited cardiac 
function. It allows continuous measurement and is more reliable at hypotonic states than 
intermittent non-invasive blood pressure measurement. Additionally, in the mechanically ventilated 
patient the observation of increased respiratory variations of the arterial blood pressure waveform 
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may help in the assessment of the fluid balance. During inspiration, increased intrathoracic pressure 
reduces venous return, i.e., preload and thus diminishes stroke volume. As a result, systolic and 
diastolic pressure decreases and increases with a short delay after inspiration and expiration, 
respectively (Figure 1A). The effect is more pronounced for the systolic pressure and is typically 
amplified with progressive hypovolemia. Furthermore, arterial cannulation allows a convenient 
withdrawal of blood for repeated blood gas analysis and additional laboratory parameters. 
Cardiac output measurement. Continuous cardiac output measurement may help to evaluate 
the volume status and to guide fluid resuscitation in patients with impaired cardiac function. As 
mentioned above, the standard device for its assessment is the pulmonary artery catheter. 
Alternatively, less invasive devices can be used considering their specific characteristics and 
limitations. The most frequently applied techniques are pulse contour / wave analysis and 
transesophageal Doppler flow measurements.[4] 
More important than a single value for cardiac output is the analysis of the time course of these 
values (trends), e.g., the response of cardiac output to fluid administration. Furthermore, cardiac 
output has to be evaluated in context with clinical examination and other hemodynamic parameters. 
For example, when cardiac output is low, fluid administration should only be performed when other 
signs of hypovolemia co-exist. However, if the patient is hypervolemic (cardiac failure), treatment 
with beta-sympathomimetic catecholamines is required to improve cardiac function.  
Cardiac filling pressures: Central venous and pulmonary artery occlusion pressure. 
Traditionally, central venous pressure (CVP) and pulmonary artery occlusion pressure (PAOP) have 
been considered to indirectly reflect heart filling, i.e., right and left ventricular preload (Figure 2A). 
CVP is widely being used to assess the fluid status in patients without significant right ventricular 
dysfunction and pulmonary alterations when large and rapid changes of the volume status occur. 
Recent studies however, revealed only a weak correlation between cardiac filling pressures and 
volumes.[5] These findings may be primarily explained by the fact that transduced intra-thoracic as 
well as intra-abdominal pressures interfere with these pressure measurement. It has to be 
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emphasized that preload according to Frank-Starling is defined as end-diastolic myocardial fiber 
tension.[6] Because this cannot be measured in a clinical setting, only surrogate markers of preload 
can be determined. Although pressure is a determinant of a compliant system like the heart, this 
refers to transmural but not intravascular pressure. Moreover, frequently observed alterations of the 
cardiac valves or obstructions of the heart cavities may introduce false measurements. 
Despite these limitations, CVP and PAOP are still being used in clinical practice worldwide. It 
is important, that interpretation of these parameters is done in the clinical context. Furthermore, 
trends towards low or high values are more predictive for hypo- or hypervolemia than absolute 
values and the dynamics of changes are essential: For example, a small increase in filling pressures 
during a fluid trial in a hypovolemic patient may indicate the need for additional fluid 
administration, whereas a dramatic increase in filling pressures may indicate imminent fluid 
overload and fluid administration needs to be restricted. 
Volumetric preload parameters. Because cardiac filling pressures do not necessarily reflect 
the patient’s volume status, easy accessible parameters to determine end-diastolic volumes are 
highly desirable. Two thermodilution based techniques provide volumetric preload parameters, 
which are calculated from cardiac output using the modified Stewart-Hamilton equation and 
indicator passage times.[7] Continuous end-diastolic volume index (CEDVI) is assessed by a 
modified pulmonary artery catheter (CCOmbo CCO/SvO2/CEDV catheter 774HF75 Edwards 
Lifescience LLC, Irvine, CA; USA). Based on the site of measurement, CEDVI reflects right heart 
end-diastolic volume (Figure 2B). Global end-diastolic volume index (GEDVI) and the closely 
related intrathoracic blood volume index (ITBVI) are determined via transpulmonary 
thermodilution (Figure 2C), which is used for the calibration of one of the less invasive cardiac 
output monitoring systems based on pulse contour analysis (PiCCOplus, Pulsion Medical Systems, 
Munich, Germany). This concept assumes that the thermal indicator travels from the site of 
injection (central venous catheter) through different central compartments connected in series (i.e. 
right atrium and ventricle, pulmonary vessels and lungs, left atrium and ventricle) to the indicator 
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detection site (a thermistor tipped arterial catheter typically inserted in the femoral artery). Based on 
different indicator passage times through these compartments, different volumes can be calculated 
(Figure 3). Thus, GEDVI includes the volume of all heart cavities and of the descending aorta. 
ITBVI additionally includes the volume of the pulmonary vessels. All volumetric preload 
parameters have shown to be superior preload indictors than cardiac filling pressures.[8-10] 
Apart from to the assessment of GEDVI and ITBVI, the PiCCO system further allows to 
calculate the extravascular lung water (EVLW, Figure 2D). EVLW may be useful to better 
characterize pulmonary edema and ARDS, to evaluate the success of different ventilatory strategies, 
and to predict outcome in ARDS. However, careful interpretation of EVLW data is required in 
presence of large pulmonary vascular obstruction (e.g., pulmonary emboli), focal lung injury or 
lung resection.[7,11] 
Pulse pressure and stroke volume variation. Variations in pulse pressure (PPV) and stroke 
volume (SVV) occur due to cyclic changes of intrathoracic pressure induced by mechanical 
ventilation. The major determinant is a reduced venous return during inspiration of positive pressure 
ventilation. PPV and SVV have been recognized as potential parameters for guiding fluid 
replacement therapy more than 20 years ago. However, only with the recent introduction of cardiac 
output monitoring devices based on pulse wave / contour analysis, automated quantification of this 
phenomenon is now possible in clinical practice (Figure 1B). The method appears to visualize the 
individual cardiac response (changes in stroke volume) related to myocardial contractility due to 
diastolic volume loading: In presence of hypovolemia, high stroke volume variations can be 
observed and the preload dependence of left ventricular function is pronounced, i.e. the ventricle 
operates on the ascending limb of the Frank-Starling curve. During volume expansion, there is a 
right-ward shift of left ventricular function on the Frank-Starling curve, which is thought to 
correspond to the observed decrease of stroke volume variation (Figure 4). PPV and SVV have 
been used to assess fluid responsiveness and have shown to be sensitive in predicting the ventricular 
response to fluid administration (i.e. sensitive detection of fluid responders). However, alteration of 
 7
vasomotor tone may influence PPV more than SVV. Moreover, the fact has to be stressed, that this 
dynamic preload assessment is only reliable in fully sedated, mechanically ventilated patients with a 
regular heart rhythm.[12,13] 
Transesophageal echocardiography. Different echocardiographic approaches allow preload 
quantification either by measuring and calculating left ventricular end-diastolic area (LVEDA) or 
volume (LVEDV). LVEDA is determined at mid-papillary level in a short axis view. However, 
different echocardiographic positions and measurements are required for the volumetric calculation 
of LVEDV. These calculations are typically based on the Simpson algorithm assuming that the 
ventricle consists of a sum of small cylinders and a truncated ellipse.[14] Conflicting results have 
been reported using the Simpson algorithm and, in daily practice, LVEDA is widely used as 
surrogate of left ventricular preload.[15] However, as this technique is highly operator dependent, 
the real benefit of echocardiography is the visualization of ventricular function, wall motion 
abnormalities and cardiac filling and the “real-time” guiding of fluid therapy in acute, critical 
hemodynamic situations. The detection of “kissing papillary muscles”, i.e., the end-systolic contact 
of these structures, is highly pathognomonic for a hypovolemic state, whereas in hypervolemia 
distended left ventricle with decreased function and mitral insufficiency as expression of an 
enlarged mitral annulus can be seen. Furthermore, echocardiography is of invaluable help as a 
diagnostic tool (e.g., detection of a papillary muscle rupture, pericardial tamponade, acute valvular 
pathologies, and dissection of the ascending aorta).[16,17] 
Microcirculation / regional blood flow. The maintenance of microcirculatory perfusion aims 
at providing an adequate tissue oxygenation. Consequently, different methods to directly visualize 
microcirculation have been developed in the last years. Nailfold microvideoscopy was the first 
technique available for bedside measurement. Unfortunately, local alterations of the vascular 
structure due to temperature changes and influences of vasoactive substances rendered readings 
unreliable. Furthermore, results may fail to represent microcirculation of target organs like the 
intestines or the brain. The recently introduced orthogonal polarization spectral imaging and the 
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sidestream dark-field technique are applied to the sublingual mucosal surface. The significance of 
these techniques has also been questioned for the same reasons as nailfold microvideoscopy. 
However, the use of these monitoring techniques revealed interesting insights into the 
hemodynamic pathophysiology of macro- and microcirculation for example in sepsis, where 
microcirculatory alterations are most likely to occur: Microcirculation improved as a result of a 
dobutamine infusion unrelated to cardiac output and mean arterial pressure in septic patients.[18] 
Furthermore, in a comparative model of septic and hemorrhagic shock, changes of microcirculation 
were also observed in hemorrhagic shock, but they were less pronounced than in septic shock. 
Resuscitation and restoration of the macrocirculation resulted in an increased microcirculation in 
hemorrhagic shock, whereas treatment failed to improve capillary blood flow in sepsic shock.[19] It 
seems that these techniques of microcirculation monitoring provide additional and necessary 
information for the optimization of end-organ perfusion. However, because they are time 
consuming and because clearly defined end-points are lacking, they have to be considered 
experimental as of today.[20] 
 
Laboratory evaluation 
Laboratory evaluation supports the assessment of a patient’s fluid status primarily by providing 
information on the effects of an inadequate end-organ perfusion. Parameters assessed by blood gas 
analysis reflect global tissue hypoperfusion, but also allow the calculation of tissue oxygen 
extraction (in combination with cardiac output measurement). Furthermore, renal function and the 
electrolyte composition of the urine provide information on the global fluid status and end-organ 
perfusion of the kidney. Finally, hormones released from myocardial cells in response to volume 
expansion and possibly increased wall stress (e.g., BNP) may provide some information on the 
patient’s volume status and help to differentiate non-cardiogenic and cardiogenic pulmonary edema 
(Table 3). 
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Arterial blood gas analysis. Inadequate tissue perfusion, i.e., impairment of oxygen delivery 
and regional hypoxia induces a change of the energy supply from aerobic to anaerobic metabolism: 
Instead of 36 only 2 ATP molecules are produced per metabolized glucose molecule, while 
pyruvate is converted to lactate. Anaerobic metabolism results in the formation of large amount of 
hydrogen ions, and a metabolic lactic acidosis develops with decreased pH and increased lactate 
level (>2meq/L). Independent of global hypoperfusion and anaerobic metabolism, lactate levels 
may also be elevated during administration of large amounts of lactated Ringer’s solution and 
reduced hepatic clearance of lactate. On the other hand, pH is a function of the available amount of 
plasma bicarbonate and arterial CO2. The interaction between pH, HCO3- and PaCO2 is explained 
by the Henderson-Hasselbalch equation: 
pH = pK + log HCO3- / 0.03(PaCO2), for clinical purposes a simplification may be sufficient: 
pH ~ HCO3- / PaCO2 
Typically, levels of bicarbonate and base excess decrease during the development of tissue 
hypoperfusion and progressive metabolic lactic acidosis, because plasma bicarbonate acts as 
hydrogen ion buffer. Base excess is defined as the amount of base required to raise 1 L of blood to a 
pH predicted from actual PCO2 and is a derived parameter from bicarbonate and pH: 
BE = HCO3 – 24.8 + (16.2 x [pH – 7.4]) 
Base excess has shown to be a better indicator of global hypoperfusion and the development of 
metabolic acidosis than pH, primarily because of the compensatory physiologic mechanisms to 
maintain the pH in a normal range.[21,22] However, base excess can also be altered by etiologies 
other than global hypoperfusion. For example, hypercholemic metabolic acidosis induced by 
infusion of normal saline, diabetic ketoacidosis, and acidosis due to chronic renal failure may result 
in a decreased base excess (increased base deficit). [23] 
Apart from these main parameters indicating global hypoperfusion, arterial blood gas analysis 
together with advanced hemodynamic monitoring may further allow to calculate how much oxygen 
is being delivered into the tissue of the body, expressed as the oxygen delivery index (DO2I): 
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DO2I (mL/min/m2) = CI x 13.4 x Hb x SaO2 
CI = cardiac index, Hb = hemoglobin concentration, SaO2 = arterial oxygen saturation 
DO2I may help to estimate a deficit in oxygen supply. Several studies demonstrate an improved 
outcome, when supranormal DO2I levels (>600 ml/min/m2) have been achieved during preoperative 
resuscitation.[24] However, conflicting results have been reported in studies applying this concept 
to trauma and septic patients.[25,26] 
Venous blood gas analysis. The oxygen saturation of venous blood is either measured in the 
pulmonary vein (mixed venous oxygen saturation = SvO2) or in the superior vena cava (central 
venous oxygenation saturation = ScvO2) using co-oximetry in order to determine the balance 
between systemic oxygen delivery and consumption (i.e., tissue oxygen extraction). Hypoperfusion 
due to hypovolemia for example results in a decreased oxygen delivery. The determination of SvO2 
requires the placement of a pulmonary artery catheter and, in order to avoid the inherent risk related 
to its use, assessment of ScvO2 via a central venous catheter is advocated.[27] SvO2 reflects the 
oxygen extraction of the total body, ScvO2 only that of the brain and the upper part of the body. 
Under physiologic conditions ScvO2 values are lower than SvO2 values (higher oxygen extraction 
by the brain), whereas in a sedated patient after major abdominal surgery SvO2 values may be 
significantly lower (higher oxygen extraction by the intestines). Thus, it has been argued that SvO2 
and ScvO2 may not necessarily be used interchangeably.[28] However, since trends of these two 
parameters show a good correlation,[29] SvO2 and ScvO2 are helpful tools for the fluid assessment 
and resuscitation in complex hemodynamic situations. Because frequent blood gas analyses are 
required, the use of a modified pulmonary artery or central venous catheter (with fibreoptic sensors 
to measure oxygen saturation) has to be considered. 
Parameters of renal function. In a patient without renal disease and diuretic therapy, 
hypovolemia and renal hypoperfusion leads to increased urea reabsorption and a proportionately 
greater elevation in BUN than plasma creatinine. Therefore, the BUN:creatinine ratio can increase 
from 10: 1 to ≥ 20:1 and help to assess this patient’s volume status. However, increased urea 
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production (hyperalimentation, glucocorticoid therapy, gastrointestinal bleeding) may also increase 
this ratio.  
Because the appropriate response to fluid deficits is an enhanced renal Na+ and water 
reabsorption, the urine composition typically reflects the patient’s fluid status. In a hypovolemic 
patient, the urine osmolality and specific gravity are generally >450 mOsm/kg and 1.015 g/mL 
because of maximal concentration of the urine (enhanced AVP secretion). Furthermore, the urine 
Na+ concentration is usually <20 mEq/L in hypovolemia. For example, if the urine Na+ 
concentration remains <20 mEq/L after fluid therapy, then the kidney is sensing persistent volume 
depletion and more fluids should be given. However, the use of urine Na+ concentration can not be 
applied to an edematous patient with heart failure or cirrhosis. In these patients, the urine Na+ 
concentration is a marker of effective circulating volume depletion but not necessarily an indicator 
for the need of more fluid. Additionally, urine Na+ concentration does not reflect the volume status 
in conditions associated with impaired Na+ reabsorption, as in acute tubular necrosis. Another 
exception is hypovolemia due to vomiting, since the associated metabolic alkalosis and increased 
filtered HCO3- impair proximal Na+ reabsorption. In this case, the urine Cl- is low (<20 mEq/L). 
Finally, in hypovolemia due to a diabetes insipidus, urine osmolality and specific gravity are 
indicative of inappropriately dilute urine. 
 
Conclusion 
Careful assessment of the fluid balance is required in the perioperative period since incorrect 
fluid therapy is associated with a considerable morbidity and mortality.[1] Protocols with endpoints 
to achieve like hemodynamic and metabolic parameters (Table 8 and 9) should help the clinician to 
provide optimal fluid therapy: Immediate restoring and / or maintaining an optimal effective 
circulating volume with sufficient oxygen carrying capacity and normal electrolyte composition is 
the primary goal (fluid and electrolyte balance).  
 12
Currently there is no single endpoint that universally diagnoses hypovolemia and hypoperfusion 
or identifies when the goals of resuscitation have been met. The trends of the resuscitation 
endpoints over time and their ability to normalize within 24 h following severe trauma has 
definitively been proven more useful. Only with frequent re-evaluation of endpoint parameters can 
the resuscitation be tailored specifically to the individual patient and change a ‘nonresponder’ into a 
‘responder’. Serum pH, bicarbonate, base deficit, and lactate have all been demonstrated to be 
metabolic indicators of the severity of hypovolemia, and help determine the adequacy of 
resuscitation. They have also proven to be more useful than estimated blood loss, heart rate and 
blood pressure.[30] Which endpoint is used to guide resuscitation is less important than how the 
results are interpreted and how the therapy is altered to return the patient to adequate global tissue 
oxygenation.[23] 
 13
Figure Legends 
Figure 1.  Arterial waveform analysis. 
Footnote:  1A. Visual assessment of pulse pressure variation. Typical pulse pressure variation 
caused by hypovolemia as a result of intermittent positive pressure ventilation. Note 
the changes of both the systolic and the diastolic arterial pressure with a higher 
decrease of the systolic pressure than of the diastolic pressure as a result of a reduced 
preload caused by inspiration, i.e. an increase of intrathoracic pressure. p = pressure, t 
= time. 
1B. Quantitative assessment of pulse pressure (PPV) and stroke volume (SVV) 
using less invasive hemodynamic monitoring device (Pulse contour analysis).  
PP max = maximal pulse pressure, PP min = minimal pulse pressure. PPV is assessed 
as % change during the ventilatory cycle according to the following equation:  
PPV (%) = (PPmax – PPmin) / PPmean 
PPmax/PPmin= mean values of the four extreme values of pulse pressure; PPmean= 
average value for this time period. 
SV max = maximal stroke volume, SV min, minimal stroke volume. SVV as % change 
of stroke volume (SV) can be determined during the same time interval accordingly: 
SVV (%) = (SVmax – SVmin) / SVmean 
SVmax/min = mean values of the four extreme values of stroke volume during a 
period of 30 sec; SVmean = average value for this time period. p = pressure, t = time. 
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 Figure 2.  Basic and advanced hemodynamic monitoring. 
Footnote:  2A. Right and left heart filling pressures: Central venous and pulmonary artery 
occlusion pressure. Central venous pressure (CVP) is measured at the transition of the 
superior vena cava and the right atrium. For pulmonary artery occlusion pressure 
(PAOP) measurement, the balloon at the tip of the pulmonary artery catheter is inflated 
and floats to the wedge position. The blood flow ceases and a hydrostatic column is 
created between the tip of the catheter and the right atrium. 
2B. Continuous end-diastolic volume index (CEDVI). Continuous end-diastolic 
volume is determined from continuous cardiac output monitoring and the indicator 
travel time in the right heart (indicator: intermittent release of small heat quantities 
from the thermal filament). 
2C. Global end-diastolic volume index (GEDVI) and intrathoracic blood volume 
index (ITBVI). Global end-diastolic volume and intrathoracic blood volume are 
calculated from cardiac output and different indicator passage time after injection 
through a central venous catheter and the detection by a thermistor tipped arterial 
catheter in the femoral artery (see Figure 3) 
2D. Extravascular lung water (EWLW). Extravascular lung water is calculated from 
cardiac output and different indicator passage time after injection through a central 
venous catheter and the detection by a thermistor tipped arterial catheter in the femoral 
artery (see Figure 3). 
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 Figure 3.  Transpulmonal thermodilution curve and typical indicator passage time required 
for the calculation of global end-diastolic volume index (GEDVI), intrathoracic 
blood volume index (ITBVI) and extravascular lung water (EVLW). 
Footnote:  MTt = Mean Transit time of the indicator, DSt = Down slope time of the indicator, δT 
= temperature change as result of thermal indicator injection. 
Global end-diastolic volume index (GEDVI), intrathoracic blood volume index 
(ITBVI) and extravascular lung water index (EVLWI) are calculated according to the 
following formulas:  
GEDVI = CO x (MTt – DSt) x BSA 
ITBVI = 1.25 x GEDVI 
EVLW = CO x ( MTt – 1.25 x [MTt – DSt]) 
 
 
Figure 4.  The concept of fluid responsiveness based on the assessment of stroke volume 
variation (SVV). 
Footnote:  EDV = end-diastolic volume, δEDV = change of end-diastolic volume induced by 
fluid application. SV = stroke volume, δSV = change of stroke volume induced by 
fluid administration. SVV large = stroke volume variation typically higher than 15%. 
SVV small = stroke volume variation smaller than 12 %. 
Fluid administration in a patient with a large SVV typically results in an increased 
EDV and an increased SV (so called “fluid responder”). During fluid administration, 
SVV decreases and travels up along an imaginary individual Frank-Starling curve. If 
SVV becomes low, further fluid administration will only induce small changes of both 
EDV and SV (shallow part of the Frank-Starling curve, so called “fluid non-
responders”). 
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Tables 
 
Table 1.  Assessment of the fluid balance in the perioperative period. 
Patients’ history 
 Preoperative history 
∗ Medical history, preexisting diseases 
∗ Preoperative volume status 
 Surgery / Intervention 
∗ Type and duration of surgery / intervention 
∗ Blood loss 
∗ Third space loss 
 Anesthesia 
∗ Type and duration of anesthesia 
∗ Fluid replacement including transfusion 
∗ Type of monitoring 
∗ Intraoperative course of physiological variables (trends) 
Patients’ current clinical condition 
∗ Physical examination 
∗ Physiological variables from routine, advanced monitoring 
∗ Laboratory parameters, medical imaging 
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Table 2. Advanced hemodynamic monitoring to assess the fluid status. 
Monitoring device  Parameter Standard values 
Invasive blood pressure  
 Visual evaluation of pressure variation   
Central venous catheter 
 Central venous pressure 
 Central venous oxygenation 
CVP  
ScvO2 
2-8 mmHg 
> 70 % 
Invasive, advanced hemodynamic monitoring (“gold standard”) 
Pulmonary artery catheter 
 Pulmonary capillary wedge pressure 
 Cardiac index 
 Stroke volume index 
 Continuous end-diastolic volume index 
 Mixed venous oxygen saturation 
PCWP 
CI 
SVI 
CEDVI 
SvO2 
8-18 mmHg 
2-3.5 L/min/m2 
35-50 mL/m2 
100-200 mL/m2 
> 75 % 
Less invasive, advanced hemodynamic monitoring 
Transpulmonary thermodilution 
 Global end-diastolic volume index 
 Intrathoracic blood volume index 
 Extravascular lung water 
GEDVI 
ITBVI 
EVLW 
700-800 ml/m2 
875-1000 ml/m2 
≤ 10 ml/kg 
Pulse contour / wave analysis 
 Pulse pressure variation 
 Stroke volume variation 
PPV 
SVV 
< 10-13 % 
< 10-13 % 
Transesophageal Doppler 
 Aortic flow measurements   
Transesophageal, transthoracic echocardiography 
 Visual evaluation 
 End-diastolic area 
 End-diastolic volume 
 
EDA 
EDV 
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Table 3. Laboratory parameters to assess the fluid balance. 
Arterial blood gas analysis   
 Metabolic acidosis (pH)  < 7.36 – 7.44 
 Lactate  < 2 mEq/L 
 Base excess (BE)  -2 – +2 mEq/L 
Laboratory parameters of renal function   
 Creatinine (Creat)  70-110 mmol/L (0.8-1.25 mg/dL) 
 Blood Urea Nitrogen (BUN)  2.1-8.9 mmol/L (6-25 mg/dL) 
  PRA ATN 
 BUN:Creatinine ratio  ≥ 20:1 10:1 – 20:1 
 Fractional sodium excretion (FENa) 
 = (Na U x Creat P) : (Na P x Creat U) x 100 
 < 1 % > 2 % 
 Urinary sodium (Nau)  < 10-20 mEq/L > 20-40 mEq/L 
 Urinary osmolality (Osmu)  > 450 mOsm/kg < 350 mOsm/kg 
Laboratory parameter of cardiac failure   
 Brain natriuretic peptide (BNP)  < 125 pg/mL 
 
PRA = pre-renal azotemia, ATN = acute tubule necrosis, U = urinary, P = plasma. 
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